Intellia Therapeutics also has fans on Wall Street. The company's current average price target of $32.3 (according to Yahoo!
Asharq Al-Awsat on MSN
Wildlife Center Announces Genetic Study Revealing Unprecedented Biodiversity in Red Sea
Asharq Al Awsat The National Center for Wildlife, in cooperation with King Abdullah University of Science and Technology (KAUST), announced new findings from an extensive study assessing biodiversity ...
The Chosun Ilbo on MSN
FDA Speeds Up Custom Gene Therapy Approvals With Existing Data
Last May, people were thrilled to learn that a 7-month-old baby who became the first in the world to receive a personalized ...
AI is set to shake up the investment management industry, but Gene Munster says the right mix of these soft skills could help ...
Over the past two decades, synthetic biology has fueled advancements across a broad range of disciplines, including agriculture, bioremediation, biofuel production, and chemical manufacturing. Today, ...
A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the ...
Chocolate prices have been rising due to complications in the supply chain, but Penn State researchers have made a ...
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
Cathy Tie, who launched her first biotech in SF's IndieBio, now leads Manhattan Genomics in controversial push to edit human ...
The neurologic disease called chronic traumatic encephalopathy or CTE has most often been found in people who experienced ...
New research posits that a genetic incompatibility between female offspring of humans and Neanderthals and their children ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback